Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Feb;12(1):1-15.
doi: 10.1007/s11030-008-9072-1. Epub 2008 Apr 12.

Emerging approaches for the syntheses of bicyclic imidazo[1,2-x]-heterocycles

Affiliations
Review

Emerging approaches for the syntheses of bicyclic imidazo[1,2-x]-heterocycles

Christopher Hulme et al. Mol Divers. 2008 Feb.

Abstract

Imidazo-[1,2-x]heterocycles are versatile building blocks for use in both a 'drug hunters' quest to discover new leads and a chemical biologists search for effective molecular tools in 'cell perturbation' studies. At the front end of the drug discovery flow chart, the last 5-10 years have witnessed the discovery of new high-throughput methodologies which very quickly have enabled access to virtual libraries of these chemo-types in the realm of 10(7) derivatives. Interestingly, these often neglected cores in patent cooperation treaty (PCT) applications appear in several highly effective marketed drugs, completing the medicinal chemists search for clinical success. Such rigid chemo-types, all containing a bridgehead nitrogen atom, are thus poised for an ever increasing impact on the discovery and development of new molecular therapeutics. The following mini-review will briefly cover therapeutic utility, chemical methodologies and automation developed to enable preparation of arrays of these chemo-types in a high-throughput manner. Synthetic emphasis is placed on a 3-component-3-center isocyanide based multi-component reaction (IMCR), which spans solution, solid phase, flourous and microwave assisted organic synthesis.

PubMed Disclaimer

References

    1. Chem Pharm Bull (Tokyo). 2006 Sep;54(9):1318-21 - PubMed
    1. J Med Chem. 1969 Jan;12(1):122-6 - PubMed
    1. Chem Biol Drug Des. 2006 Jan;67(1):2-4 - PubMed
    1. Pharmacol Biochem Behav. 1988 Apr;29(4):803-6 - PubMed
    1. J Org Chem. 2007 Feb 2;72(3):1013-6 - PubMed

MeSH terms

Substances

LinkOut - more resources